Comparative Analysis of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Between Preeclampsia and Normal Pregnant Women

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2020 Jun 27

PMID 32587622

Citations 2

Authors

Han-Sung Hwang

Yong-Sun Maeng

Affiliations

Soon will be listed here.

Abstract

Preeclampsia is a syndrome characterized by deterioration of either the maternal condition or the fetal condition. The adverse intrauterine environment made by preeclampsia results into intrauterine growth restriction and increased risk of a variety of diseases in future life. Given the adverse environment of fetal circulation made in the preeclamptic condition, and the role of mesenchymal stem cell (MSC) as a multipotent progenitor cell, we hypothesized that MSCs derived from human umbilical cord blood (hUCB-MSCs) obtained from preeclampsia are adversely altered or affected compared with normal pregnancy. The aim of this study was to analyze the biological characteristics and compare the functional abilities and gene expression patterns of hUCB-MSCs originating from pregnant women with and without severe preeclampsia. hUCB-MSCs were isolated and cultured from 28 pregnant women with severe preeclampsia and 30 normal pregnant women. hUCB-MSCs obtained from women with preeclampsia were less proliferative and more senescent and had lower telomerase activity and higher ROS activity than cells from women with normal pregnancy. In addition, many senescence-related differentially expressed genes (DEGs) were identified by analysis of microarray gene expression profiles and significantly associated with the Gene Ontology term cell aging. In conclusion, hUCB-MSCs obtained from women with preeclampsia showed the poorly proliferative, more senescent, and decreased telomerase activity, and these characters may be related with functional impairment of MSC from preeclampsia compared with cells from normal pregnancy.

Citing Articles

Microchimerism and pregnancy complications with placental dysfunction.

Jacobsen D, Fjeldstad H, Olsen M, Sugulle M, Staff A Semin Immunopathol. 2025; 47(1):21.

PMID: 40067448 PMC: 11897092. DOI: 10.1007/s00281-025-01045-w.

EndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment.

Zhang X, Ren Z, Jiang Z Mol Cell Biochem. 2022; 478(4):755-765.

PMID: 36083511 DOI: 10.1007/s11010-022-04544-8.

The pathological and therapeutic roles of mesenchymal stem cells in preeclampsia.

Jin S, Wu C, Chen M, Sun D, Zhang H Front Med (Lausanne). 2022; 9:923334.

PMID: 35966876 PMC: 9370554. DOI: 10.3389/fmed.2022.923334.

References

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

Hwang H, Maeng Y, Park Y, Koos B, Kwon Y, Kim Y . Increased senescence and reduced functional ability of fetal endothelial progenitor cells in pregnancies complicated by preeclampsia without intrauterine growth restriction. Am J Obstet Gynecol. 2008; 199(3):259.e1-7. DOI: 10.1016/j.ajog.2008.06.060. View

de Magalhaes J, Chainiaux F, DE Longueville F, Mainfroid V, Migeot V, Marcq L . Gene expression and regulation in H2O2-induced premature senescence of human foreskin fibroblasts expressing or not telomerase. Exp Gerontol. 2004; 39(9):1379-89. DOI: 10.1016/j.exger.2004.06.004. View

Lewis K, Wuttke D . Telomerase and telomere-associated proteins: structural insights into mechanism and evolution. Structure. 2012; 20(1):28-39. PMC: 4180718. DOI: 10.1016/j.str.2011.10.017. View

Igura K, Zhang X, Takahashi K, Mitsuru A, Yamaguchi S, Takashi T . Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy. 2005; 6(6):543-53. DOI: 10.1080/14653240410005366-1. View

Zvaifler N, Marinova-Mutafchieva L, Adams G, Edwards C, Moss J, Burger J . Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000; 2(6):477-88. PMC: 17820. DOI: 10.1186/ar130. View

Ajne G, Ahlborg G, Wolff K, Nisell H . Contribution of endogenous endothelin-1 to basal vascular tone during normal pregnancy and preeclampsia. Am J Obstet Gynecol. 2005; 193(1):234-40. DOI: 10.1016/j.ajog.2004.11.023. View

Valle-Prieto A, Conget P . Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev. 2010; 19(12):1885-93. DOI: 10.1089/scd.2010.0093. View

Wang C, Wen M, Wang H, Hsieh I, Li Y, Liu P . Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation. 2008; 118(21):2166-73. PMC: 2656770. DOI: 10.1161/CIRCULATIONAHA.108.790469. View

10.

Debacq-Chainiaux F, Erusalimsky J, Campisi J, Toussaint O . Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009; 4(12):1798-806. DOI: 10.1038/nprot.2009.191. View

11.

Fossett E, Khan W, Pastides P, Adesida A . The effects of ageing on proliferation potential, differentiation potential and cell surface characterisation of human mesenchymal stem cells. Curr Stem Cell Res Ther. 2012; 7(4):282-6. DOI: 10.2174/157488812800793027. View

12.

Lorthongpanich C, Thumanu K, Tangkiettrakul K, Jiamvoraphong N, Laowtammathron C, Damkham N . YAP as a key regulator of adipo-osteogenic differentiation in human MSCs. Stem Cell Res Ther. 2019; 10(1):402. PMC: 6921580. DOI: 10.1186/s13287-019-1494-4. View

13.

Jo C, Ahn H, Kim H, Seong S, Lee M . Surface characterization and chondrogenic differentiation of mesenchymal stromal cells derived from synovium. Cytotherapy. 2007; 9(4):316-27. DOI: 10.1080/14653240701291620. View

14.

Aardema M, Saro M, Lander M, De Wolf B, Oosterhof H, Aarnoudse J . Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities?. Clin Sci (Lond). 2003; 106(4):377-82. DOI: 10.1042/CS20030385. View

15.

Cardenas C, Kwon J, Maeng Y . Human Cord Blood-Derived CD133/C-Kit/Lin Cells Have Bipotential Ability to Differentiate into Mesenchymal Stem Cells and Outgrowth Endothelial Cells. Stem Cells Int. 2017; 2016:7162160. PMC: 5203918. DOI: 10.1155/2016/7162160. View

16.

Wang Q, Zou M . Measurement of Reactive Oxygen Species (ROS) and Mitochondrial ROS in AMPK Knockout Mice Blood Vessels. Methods Mol Biol. 2018; 1732:507-517. PMC: 6407612. DOI: 10.1007/978-1-4939-7598-3_32. View

17.

Majerska J, Sykorova E, Fajkus J . Non-telomeric activities of telomerase. Mol Biosyst. 2011; 7(4):1013-23. DOI: 10.1039/c0mb00268b. View

18.

FRIEDENSTEIN A, Gorskaja J, Kulagina N . Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976; 4(5):267-74. View

19.

Cheng S, Yang J, Rifas L, Zhang S, Avioli L . Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology. 1994; 134(1):277-86. DOI: 10.1210/endo.134.1.8275945. View

20.

Myatt L . Placental adaptive responses and fetal programming. J Physiol. 2006; 572(Pt 1):25-30. PMC: 1779654. DOI: 10.1113/jphysiol.2006.104968. View